Prevest Denpro Ltd (PREVEST) — shareholding pattern, promoter holding, financials and share price
About Prevest Denpro Ltd (PREVEST)
Prevest Denpro Ltd operates in the Medical Equipment & Supplies industry, within the Healthcare sector. It trades on the NSE as PREVEST and on the BSE under scrip code 543363. Its ISIN is INE0GAO01018.
Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.
Prevest Denpro Limited is a leading dental materials manufacturer, providing a wide range of dental products tailored to fulfill various clinical needs, including endodontics and orthodontics. They have a strong international presence with exports to over 90 countries.
The company has achieved a notable 24% growth in export revenues despite currency volatility, indicating robust demand and expanded reach in international markets.
Listed peers in Medical Equipment & Supplies: Vasa Denticity Ltd, Hemant Surgical Industries Ltd, Yash Optics & Lens Ltd, Aprameya Engineering Ltd, Nureca Ltd, Earkart Limited.
Valuation & Returns
10 Jul 2026At ₹380.15 a share on 10 Jul 2026, Prevest Denpro Ltd (PREVEST) was valued at a price-to-earnings ratio of 22.27x against an industry P/E of 44.11x and a price-to-book of 4.32x on a book value of ₹87.95 per share as of Mar 2025. Solomo computes return on equity of 19.41% and return on capital employed of 26.15% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 22.27x
- Industry P/E
- 44.11x
- P/B
- 4.32x
- EPS (TTM)
- ₹17.07
- Book value / share
- ₹87.95
- ROE
- 19.41%
- ROCE
- 26.15%
- ROA
- 18.21%
- Debt / equity
- 0x
- Dividend yield
- 0.26%
- EBITDA margin
- 41.25%
- 52-week range
- ₹318.15 – ₹622.05
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Prevest Denpro Ltd (PREVEST) reported revenue of ₹72 crore, net profit of ₹20 crore and earnings per share of ₹17.07. That compares with revenue of ₹63 crore and net profit of ₹18 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹18.94 crore and net profit ₹5.82 crore (consolidated).
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue (₹ cr) | 56 | 63 | 72 |
| Net profit (₹ cr) | 16 | 18 | 20 |
| EPS (₹) | 13.45 | 15.13 | 17.07 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 22.60% | 18.28% | 11.03% |
| Profit growth | 29.44% | 16.31% | 12.52% |
| Stock price CAGR | - | -10% | -37% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 73.6% of Prevest Denpro Ltd (PREVEST) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.65% and domestic institutional investors (DII) hold 0.79%. Market capitalisation was ₹456 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2021.
Largest disclosed public shareholders in Jun 2026: HUF 2.19%, THERMO CAPITAL PRIVATE LIMITED 1.3%, PANKAJ PRASOON AND (HUF) 1.2%, ASHIKA GLOBAL FINANCE PRIVATE LIMITED 1.13%, SHARAD KANAYALAL SHAH 1.08%, Girish Paman Vanvari 1.02%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 73.6% | - | 0.65% | 0.79% | 26.4% |
| Mar 2026 | 73.6% | - | 0.65% | 0.77% | 26.4% |
| Dec 2025 | 73.6% | - | 0.65% | 0.77% | 26.4% |
| Sep 2025 | 73.6% | - | 0.63% | 0.75% | 26.4% |
| Jun 2025 | 73.6% | - | 0.63% | 1.22% | 26.4% |
| Mar 2025 | 73.6% | - | 0.63% | 1.28% | 26.4% |
| Dec 2024 | 73.6% | - | 0.63% | 0.71% | 26.4% |
| Sep 2024 | 73.6% | - | 0.63% | 0.68% | 26.4% |